#VisualAbstract: Nerinetide Does Not Improve Outcomes in Acute Ischaemic Stroke in Patients Undergoing Endovascular Thrombectomy
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be...
#VisualAbstract: Obinutuzumab Plus Standard Therapy Provided Complete Renal Response in Active Lupus Nephritis
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced...
Polypharmacy associated with greater risk of mortality and hospitalizations in elderly
1. Polypharmacy was associated with a greater risk of mortality and hospitalizations at one and five years. Evidence Rating Level:...
#VisualAbstract: Simvastatin and Rifaximin Does Not Improve Outcomes in Decompensated Cirrhosis
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced...
#VisualAbstract: Endovascular Treatment Does Not Improve Outcomes in Stroke Due to Occlusion of Medium or Distal Vessels
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced...
#VisualAbstract: Apixaban is Superior to Aspirin for Stroke Prevention in People with Subclinical Atrial Fibrillation
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be...
#VisualAbstract: Iptacopan Reduced Proteinuria in Patients with IgA Nephropathy
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced...
#VisualAbstract: Adjuvant Atezolizumab Does Not Provide Benefit in Early Triple-Negative Breast Cancer
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced...
#VisualAbstract: Liraglutide for 56 Weeks plus lifestyle interventions reduced BMI and Body Weight in Children with Obesity
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced...
#VisualAbstract: Abelacimab is Safer Than Rivaroxaban in Patients with Atrial Fibrillation
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced...
